Thrombotic Thrombocytopenic Purpura Post COVID Vaccination o | 97301

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Thrombotic Thrombocytopenic Purpura Post COVID Vaccination or TTP in COVID-19

Author(s): Vidhi Jain, Swaroopa Chakole*, Trishla Jain and Ayushi Shastri


Background: Coronavirus disease 2019 or COVID-19 is the medical disaster that is still ongoing across the world. The disease is still evolving and changing clinical manifestations of the disease making the containment of the spread more difficult.

Summary: After seeing the constantly changing clinical manifestation of COVID-19, it is now imperative that vaccination has no alternative in the fight against COVID-19 pandemic.

Thrombocytopenia is the condition which is not common but it can be cured. But post thrombotic thrombocytopenic purpura can be dangerous. Generally the post vaccination, the adverse impact can be seen within half to one hour. But in rare cases, vaccinated persons have experience such symptoms after several hours post vaccination. The position of clots in the body may define the severity of the patients symptoms and clots in vital and sensitive area can be life threatening.

Conclusion: The rare events should not be generalized and vaccination drive should not get hampered as it is the only viable option available to contain the viral spread. More trans-boundary cohort study is needed to correlate the vaccination with any kind of adverse impact.

Share this article